Interventional Psychiatry Program, St Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Department of Electrical, Computer, and Biomedical Engineering, Toronto Metropolitan University, Toronto, ON, Canada.
JMIR Res Protoc. 2024 May 6;13:e54180. doi: 10.2196/54180.
Staffing and resource shortages, especially during the COVID-19 pandemic, have increased stress levels among health care workers. Many health care workers have reported feeling unable to maintain the quality of care expected within their profession, which, at times, may lead to moral distress and moral injury. Currently, interventions for moral distress and moral injury are limited.
This study has the following aims: (1) to characterize and reduce stress and moral distress related to decision-making in morally complex situations using a virtual reality (VR) scenario and a didactic intervention; (2) to identify features contributing to mental health outcomes using wearable, physiological, and self-reported questionnaire data; and (3) to create a personal digital phenotype profile that characterizes stress and moral distress at the individual level.
This will be a single cohort, pre- and posttest study of 100 nursing professionals in Ontario, Canada. Participants will undergo a VR simulation that requires them to make morally complex decisions related to patient care, which will be administered before and after an educational video on techniques to mitigate distress. During the VR session, participants will complete questionnaires measuring their distress and moral distress, and physiological data (electrocardiogram, electrodermal activity, plethysmography, and respiration) will be collected to assess their stress response. In a subsequent 12-week follow-up period, participants will complete regular assessments measuring clinical outcomes, including distress, moral distress, anxiety, depression, and loneliness. A wearable device will also be used to collect continuous data for 2 weeks before, throughout, and for 12 weeks after the VR session. A pre-post comparison will be conducted to analyze the effects of the VR intervention, and machine learning will be used to create a personal digital phenotype profile for each participant using the physiological, wearable, and self-reported data. Finally, thematic analysis of post-VR debriefing sessions and exit interviews will examine reoccurring codes and overarching themes expressed across participants' experiences.
The study was funded in 2022 and received research ethics board approval in April 2023. The study is ongoing.
It is expected that the VR scenario will elicit stress and moral distress. Additionally, the didactic intervention is anticipated to improve understanding of and decrease feelings of stress and moral distress. Models of digital phenotypes developed and integrated with wearables could allow for the prediction of risk and the assessment of treatment responses in individuals experiencing moral distress in real-time and naturalistic contexts. This paradigm could also be used in other populations prone to moral distress and injury, such as military and public safety personnel.
ClinicalTrials.gov NCT05923398; https://clinicaltrials.gov/study/NCT05923398.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/54180.
人员和资源短缺,尤其是在 COVID-19 大流行期间,增加了医护人员的压力水平。许多医护人员报告说,他们无法保持专业护理所期望的质量,这有时可能导致道德困境和道德伤害。目前,针对道德困境和道德伤害的干预措施有限。
本研究有以下目的:(1)使用虚拟现实 (VR) 场景和教学干预措施来描述和减轻与道德复杂情境下决策相关的压力和道德困境;(2)使用可穿戴、生理和自我报告问卷数据确定对心理健康结果有贡献的特征;(3)创建一个个人数字表型特征,以个体水平描述压力和道德困境。
这将是一项在加拿大安大略省进行的 100 名护理专业人员的单队列、前后测试研究。参与者将进行一项 VR 模拟,要求他们在与患者护理相关的道德复杂情况下做出决策,该模拟将在关于减轻痛苦的技术的教育视频之前和之后进行。在 VR 会议期间,参与者将完成衡量他们的痛苦和道德困境的问卷,以及收集生理数据(心电图、皮肤电活动、体积描记术和呼吸)以评估他们的应激反应。在随后的 12 周随访期间,参与者将定期评估包括痛苦、道德困境、焦虑、抑郁和孤独在内的临床结果。还将使用可穿戴设备在 VR 会议之前、期间和之后的两周内连续收集数据。将进行前后比较以分析 VR 干预的效果,并且将使用生理、可穿戴和自我报告数据为每个参与者创建个人数字表型特征。最后,对 VR 后讨论和退出访谈的主题分析将检查参与者经历中反复出现的代码和总体主题。
该研究于 2022 年获得资金,并于 2023 年 4 月获得研究伦理委员会的批准。该研究正在进行中。
预计 VR 场景将引起压力和道德困境。此外,教学干预预计将提高对压力和道德困境的理解,并减轻其感受。开发并整合可穿戴设备的数字表型模型可以允许在真实和自然的环境中实时预测经历道德困境的个体的风险,并评估治疗反应。该范式还可以用于其他容易出现道德困境和伤害的人群,例如军事和公共安全人员。
ClinicalTrials.gov NCT05923398;https://clinicaltrials.gov/study/NCT05923398。
国际注册报告标识符(IRRID):DERR1-10.2196/54180。